Targeting the Post‑Replicative Hyperaccessibility Window to Erase Resistant Aging Epigenetic Marks in iPSCs

Hypothesis

Transiently enhancing DNA demethylation or histone acetylation specifically during the post‑replicative hyperaccessibility window can preferentially erase OSKM‑resistant age‑associated CpG sites and repressive histone marks without compromising the somatic memory required for lineage‑biased differentiation.

Mechanistic Rationale

• iPSC reprogramming leaves behind a subset of aging‑related DNA methylation marks and H3K9me3/H3K27me3 foci that resist OSKM‑driven erasure (2, 3).
• DNA replication creates a brief period of heightened chromatin openness on newly synthesized strands, rendering them more susceptible to enzymatic modification (6).
• Coupling this window with targeted epigenetic editors (e.g., dCas9‑TET1 for demethylation or dCas9‑p300 for acetylation) should allow precise erasure of resistant marks while leaving the bulk of the genome untouched.
• Fast‑dividing iPSC subpopulations exhibit greater chromatin accessibility at pluripotency loci, predicting successful reprogramming (5). Enriching for these cells synchronizes the population in S‑phase, increasing the fraction of nuclei experiencing the hyperaccessible state.

Testable Predictions

1. Applying a dCas9‑TET1 system guided to OSKM‑resistant CpG sites during a 2‑hour pulse after thymidine block release will reduce epigenetic age measured by the Horvath clock by ≥1.5 years relative to controls.
2. The same treatment will decrease H3K9me3/H3K27me3 signal at pericentromeric heterochromatin by ≥30% (IF quantification) without altering expression of somatic‑memory genes (e.g., HOXA lineage markers).
3. Treated iPSCs will retain lineage‑biased differentiation propensity toward their cell‑of‑origin but show improved pluripotency marker uniformity (OCT4, NANOG) and teratoma formation capacity.

Experimental Design

• Cell source: Human fibroblasts from donors aged 60‑80 reprogrammed with OSKM to generate iPSCs.
• Synchronization: Double thymidine block → release; collect cells 0‑2 h post‑release (peak hyperaccessibility).
• Epigenetic editing: Lentiviral delivery of dCas9‑TET1 fused to a fluorescent reporter; guide RNAs targeting the top 50 age‑associated CpG sites identified in 3.
• Controls: (i) non‑targeting gRNA, (ii) dCas9‑dead (no effector), (iii) untreated.
• Readouts:
  • Whole‑genome bisulfite sequencing (WGBS) for methylation age.
  • CUT&RUN for H3K9me3/H3K27me3.
  • RNA‑seq to assess somatic‑memory transcriptome.
  • Flow cytometry for OCT4/NANOG heterogeneity.
  • Differentiation assays toward fibroblast‑lineage and ectoderm/mesoderm/endoderm.

Potential Outcomes and Interpretation

• Success: Significant reduction in epigenetic age and repressive marks with preserved somatic‑gene expression supports the hypothesis that the post‑replicative window is a exploitable bottleneck for precise epigenetic rejuvenation.
• Failure: No change in age marks or loss of somatic memory would indicate that either the hyperaccessibility window is insufficiently targeted or that resistant marks are protected by higher‑order structures beyond nucleosome accessibility.

Broader Impact

If validated, this approach could refine partial reprogramming protocols, enabling a ‘reset‑and‑preserve’ strategy that mitigates the rejuvenation gap while maintaining functional somatic identity for disease modeling and autologous cell therapy.